| __timestamp | Eli Lilly and Company | Incyte Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 4733600000 | 347523000 |
| Thursday, January 1, 2015 | 4796400000 | 479514000 |
| Friday, January 1, 2016 | 5243900000 | 581861000 |
| Sunday, January 1, 2017 | 5281800000 | 1326361000 |
| Monday, January 1, 2018 | 5051200000 | 1197957000 |
| Tuesday, January 1, 2019 | 5595000000 | 1154111000 |
| Wednesday, January 1, 2020 | 6085700000 | 2215942000 |
| Friday, January 1, 2021 | 7025900000 | 1458179000 |
| Saturday, January 1, 2022 | 7190800000 | 1585936000 |
| Sunday, January 1, 2023 | 9313400000 | 1627594000 |
| Monday, January 1, 2024 | 14271000000 | 2606848000 |
In pursuit of knowledge
In the competitive world of pharmaceuticals, research and development (R&D) is the lifeblood of innovation. Over the past decade, Eli Lilly and Company and Incyte Corporation have demonstrated contrasting strategies in their R&D investments.
Eli Lilly has consistently increased its R&D spending, with a notable 97% rise from 2014 to 2023. This strategic investment underscores their commitment to pioneering new treatments and maintaining a competitive edge in the market.
Incyte Corporation, while smaller in scale, has also shown a significant increase in R&D expenditure, growing by approximately 368% over the same period. This reflects their focused approach to developing niche therapies.
Both companies exemplify the critical role of R&D in driving pharmaceutical advancements, albeit through different scales and strategies.
Eli Lilly and Company or Pfizer Inc.: Who Invests More in Innovation?
R&D Insights: How Eli Lilly and Company and Intra-Cellular Therapies, Inc. Allocate Funds
Eli Lilly and Company vs Incyte Corporation: Efficiency in Cost of Revenue Explored
Who Prioritizes Innovation? R&D Spending Compared for Eli Lilly and Company and Genmab A/S
Who Prioritizes Innovation? R&D Spending Compared for Eli Lilly and Company and Rhythm Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Eli Lilly and Company and Celldex Therapeutics, Inc.
Comparing Innovation Spending: Eli Lilly and Company and Evotec SE
Research and Development Expenses Breakdown: Incyte Corporation vs ADMA Biologics, Inc.
Research and Development Investment: Incyte Corporation vs CRISPR Therapeutics AG
Research and Development: Comparing Key Metrics for Incyte Corporation and Xencor, Inc.
Research and Development Expenses Breakdown: Incyte Corporation vs Novavax, Inc.